Study of Dietary Patterns and Food Diversity in Russian GERD Patients

NCT ID: NCT04252144

Last Updated: 2022-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-30

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess food diversity and dietary patterns in Russian GERD patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study of dietary patterns may provide complex vision of an association between consumption of specific foods, or groups of food products and manifestations of gastroesophageal reflux disease (symptoms: heartburn and acid regurgitation; endoscopic findings - oesophagitis). Only limited data on this matter are published to the moment and they predominantly concerns outcomes of gastroesophageal reflux disease (oesophageal adenocarcinoma or Barrett's oesophagus). Taking into the consideration that earlier studies found significant differences in consumption of nutrients in different world regions, new data on food patterns of dietary patterns in Russian GERD patients could partly fill in the gap of knowledge on this particular matter.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroesophageal; Reflux With Esophagitis Gastroesophageal Reflux GERD Heartburn Non-erosive Reflux Disease Esophagitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

Dietary assessment with the use of computer-based food frequency questionnaire will be performed to patients with established diagnosis of gastroesophageal reflux disease in comparison to the representatives of a control group (without the disease).
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GERD

Patients with verified gastroesophageal reflux disease

Group Type EXPERIMENTAL

Dietary assessment

Intervention Type PROCEDURE

Dietary assessment is not within standards of care for patients with gastroesophageal reflux disease in Russia. Subjects enrolled to the study are to be interviewed on most common foods consumption in terms of frequency of use and sizes of portions.

Contol

Mostly healthy subjects who have no symptoms and other manifestations of gastroesophageal reflux disease by complex examination

Group Type OTHER

Dietary assessment

Intervention Type PROCEDURE

Dietary assessment is not within standards of care for patients with gastroesophageal reflux disease in Russia. Subjects enrolled to the study are to be interviewed on most common foods consumption in terms of frequency of use and sizes of portions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary assessment

Dietary assessment is not within standards of care for patients with gastroesophageal reflux disease in Russia. Subjects enrolled to the study are to be interviewed on most common foods consumption in terms of frequency of use and sizes of portions.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Food frequency questionnaire

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* willingness to participate (signed the informed consent form);
* willingness to follow all the required procedures;

Exclusion Criteria

* Pregnant or breast-feeding females;
* Neoplasms, current or by the medical history (except local skin cancer successfully treated);
* History of chest or abdominal surgery, except appendectomy and cholecistectomy (in case when no consequences of these operations like adhesive disease of the abdominal cavity are present);
* Co-morbid conditions which can influence or mask the symptoms of GERD (including, but not limited to: ischaemic heart disease, severe pulmonary disease, severe depression or anxiety, etc);
* the use of concomitant medications that may influence on the symptoms or other manifestations of gastroesophageal reflux disease: NSAIDs, corticosteroids (except topic ones for no longer than 2 weeks), any medications directly influencing mood and function of central nervous system (antidepressants, anxiolytics, anti-anxiety agents, anticonvulsant etc) at the moment of enrolment and during a 2 half-life period of the certain drug;
* the use of medications that influence gastric secretion at the time of enrolment and during 2 week before it;
* any condition of the patient which makes the participation of the patient in the study unreasonable or put him at risk of the condition's exacerbation
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Russian Science Foundation

OTHER

Sponsor Role collaborator

Russian Academy of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vasily Isakov

MD, PhD, Professor, AGAF

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vasily Isakov, MD, PhD, Professor, AGAF

Role: STUDY_CHAIR

FRC nutrition and biotechnology

Sergey Morozov, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

FRC Nutrition and Biotechnology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gastroenterology and Hepatology, FRC Nutrition and Biotechnology

Moscow, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sergey Morozov, MD, PhD

Role: CONTACT

+79104681801

Vasily Kropochev, MD

Role: CONTACT

+74997943572

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sergey Morozov, MD, PhD

Role: primary

+74996131091

Vasily Kropochev, MD

Role: backup

+74997943572

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-76-30014 GERD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.